Synergistic Cellular and Biotherapeutic Agent Delivery System

A novel system integrating nanoporous materials with AI, IoT, blockchain, and new materials to create a more powerful, personalized, and secure cellular and biotherapeutic agent delivery platform.

The original patent provided a foundational invention for implantable cellular and biotherapeutic agent delivery canisters. However, it lacked the capabilities for real-time monitoring, personalized treatment, and secure tracking. The new inventive concept addresses these limitations by synergistically combining the nanoporous material with distinct technologies to create a more comprehensive and effective system.

The synergistic system comprises an implantable canister with a nanoporous material, an IoT sensor for real-time monitoring, an AI-powered diagnostic system for personalized treatment, and a blockchain-based platform for secure tracking. The hybrid material integrates a nanoporous metal matrix with a biocompatible polymer and a conductive material for enhanced sensing and monitoring capabilities. The system enables remote monitoring and control, predictive analytics, and real-time adjustments to delivery parameters.

The new claims introduce a novel combination of technologies that provides a more powerful and comprehensive system for cellular and biotherapeutic agent delivery. The inventive step lies in the synergistic integration of AI, IoT, blockchain, and new materials with the nanoporous material, enabling real-time monitoring, personalized treatment, and secure tracking.

Alternative embodiments may include varying the type of IoT sensor, AI algorithm, or blockchain platform used. Additionally, the hybrid material could be modified to incorporate different biocompatible polymers or conductive materials. The system could also be adapted for use in various medical applications, such as cancer treatment or regenerative medicine.

The synergistic cellular and biotherapeutic agent delivery system has significant commercial potential in the pharmaceutical, biotechnology, and medical device industries. Target markets include companies developing personalized medicine solutions, IoT-enabled healthcare devices, and secure data management platforms for healthcare applications.